Synergism between urinary prothrombin fragment 1 and urine: A comparison of inhibitory activities in stone-prone and stone-free population groups

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 9, 2002, Pages 930-936

  Webber, Dawn ^a   Rodgers, Allen L ^a   Sturrock, Edward D ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Crystal aggregation; Crystal growth; Crystallisation; Inhibition; Protein

Indexed keywords

CALCIUM OXALATE; PROTHROMBIN; CARBON; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; PROTHROMBIN FRAGMENT 1;

ARTICLE; CALCIUM OXALATE STONE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; CRYSTALLIZATION; HUMAN; ISOTOPE LABELING; MALE; MASS SCREENING; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PURIFICATION; RACE DIFFERENCE; SCANNING ELECTRON MICROSCOPY; SOUTH AFRICA; ULTRAFILTRATION; URINALYSIS; CAUCASIAN; CHEMISTRY; COMPARATIVE STUDY; METABOLISM; NEGRO; NEPHROLITHIASIS; PRECIPITATION; URINE;

PIERINAE;

AFRICAN CONTINENTAL ANCESTRY GROUP; CALCIUM OXALATE; CARBON RADIOISOTOPES; CRYSTALLIZATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; KIDNEY CALCULI; MALE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PEPTIDE FRAGMENTS; PRECIPITATION; PROTEIN PRECURSORS; PROTHROMBIN; URINE;

EID: 0036408530     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.163     Document Type: Article

References (28)

1. Vermooten V. The occurrence of renal calculi and their possible relation to diet. J Am Med Ass 1937; 109:857-9.
2. Meyers AM, Whalley N, Zakolski WJ, Shar T. Chemical composition of the urine in the normal black and white population. In: Ryall RL, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR, editors. Urolithiasis 2. New York: Plenum Press, 1994:422.
3. Whalley N, Moreas M, Shar T, Pretorius S, Meyer A. Lithogenic risk factors in the urine of black and white subjects. Br J Urol 1998; 82:785-90.
4. Craig TA, Brandt W, Rodgers AL. Inhibitory activity of Tamm-Horsfall mucoprotein isolated from two different population groups. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger GM, editors. Urolithiasis 2000. Cape Town: University of Cape Town, 2000:119-20.
5. Lewandowski S, Rodgers A, Schloss I. The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone forming black and white South African subjects. Br J Urol 2001; 87:307-11.
6. Modlin M. The Aetiology of renal stone: a new concept arising from studies on a stone-free population. Annals of the Royal College of Surgeons of England 1967; 40:155-78.
7. Durrbaum D, Rodgers AL, Sturrock ED. A study of crystal matrix extract and urinary prothrombin 1 from a stone-prone and stone-free population. Urol Res 2001; 29:83-8.
8. Hess B. Tamm-Horsfall glycoprotein. Inhibitor or promoter of calcium oxalate monohydrate crystallisation process? Urol Res 1992; 20:83-6.
9. Dean CJ, Kanellos J, Pham H, Gomes M, Oates A, Grover P, et al. Calcium oxalate crystallisation in vitro effect of inter-α-inhibitor and derivatives. In: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A, editors. Kidney Stones Proceedings of the 8th European Symposium on Urolithiasis. Parma: Editoriale Bios, 1999:291-3.
10. Coe FL, Nakagawa Y, Asplin J, Parks JH. Role of nephrocalcin in inhibition of calcium oxalate crystallisation and nephrolithiasis. Miner Electrolyte Metab 1994; 20:378-84.
11. Ryall RL, Grover PK, Stapleton AMF, Barrell DK, Tang Y, Moritz RL, et al. The urinary F1 activation peptide of human prothrombin is a potential inhibitor of calcium oxalate crystallisation in undiluted human urine in vitro. Clin Sci 1995; 89:533-41.
12. Doyle IR, Ryall RL, Marshall VR. Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highlyselective phenomenon. Clin Chem 1991; 37:1589-94.
13. Asplin JR, Arsenault D, Parks JH, Coe FH, Hoyer JR. Contribution of human uropontin to inhibition of calcium oxalate crystallisation. Kidney Int 1998; 53:194-9.
14. Ryall RL, Harnett RM, Hibberd CM, Edyvane KA, Marshall VR. Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted urine. Urol Res 1991; 19:181-8.
15. Stapleton AM, Dawson CJ, Grover PK, Hohmann A, Comacchio R, Boswarva V, et al. Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix. Kidney Int 1996; 49:880-8.
16. Stapleton AMF, Seymour AE, Brennan JS, Doyle IR, Marshall VR, Ryall RL. Immunohistochemical distribution and quantification of crystal matrix protein. Kidney Int 1993; 44:817-24.
17. Morse RM, Resnick MI. A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallisation. J Urol 1998; 139:602-8.
18. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL2: a basic computer programme for the calculation of urinary supersaturation. J Urol 1985; 134:1242-4.
19. Ryall RL, Hibberd CM, Marshall VR. A method for studying inhibitory activity in whole urine. Urol Res 1985; 13:285-9.
20. Doyle IR, Marshall VR, Dawson CJ, Ryall RL. Calcium oxalate crystal matrix effect: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro. Urol Res 1995; 23:53-62.
21. Fleming DE, Doyle IR, Evans N, Marshall VR, Parkinson GM, Ryall RL. Proteins associated with calcium oxalate crystals formed in human urine are intracrystalline. In: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A, editors. Kidney Stones Proceedings of the 8th European Symposium on Urolithiasis. Parma: Editoriale Bios, 1999:359-61.
22. Ryall RL, Fleming DE, Doyle IR, Evans AE, Dean CJ, Marshall VR. Intracrystalline proteins and the hidden ultrastructure of calcium oxalate crystals: implications for kidney stone formation. J Struc Biol 2001; 134:5-14.
23. Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, et al. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Kidney Int 1999; 55:1776-86.
24. Hennequin C, Tardivel S, Medetognon J, Drueke T, Daudon M, Lacour B. A stable animal model of diet-induced calcium oxalate crystalluria. Urol Res 1998; 26:57-63.
25. Ryall RL, Chauvet MC, Grover PK. 2001: A space oddity. In: Kok DJ, Romijn HC, Verhagen P, Verkoelen CF, editors. Eurolithiasis 9th European symposium on urolithiasis. Maastricht: Shaker Publishing, 2001:273-4.
26. ++ binding properties of human prothrombin. Biochimie 1976; 58:391-4.
27. Bloom JC, Mann KG. Metal ion induced conformational transitions of prothrombin and prothrombin fragment 1. Biochemistry 1978; 17:4430-8.
28. Grover PK, Ryall RL. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro. Eur J Biochem 1999; 263:50-6.